Original ArticlesMaintenance Dialysis
You have accessRestricted Access
Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes
Rachel Whitty, Joanne M. Bargman, Alex Kiss, Linda Dresser and Philip Lui
CJASN December 2017, 12 (12) 2016-2022; DOI: https://doi.org/10.2215/CJN.00630117
Rachel Whitty
*Laboratory Medicine Program,
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
Joanne M. Bargman
‡Department of Medicine,
Alex Kiss
§Department of Research Design and Biostatistics, Sunnybrook Research Institute, Toronto, Ontario, Canada
Linda Dresser
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
‖Antimicrobial Stewardship Program, and
Philip Lui
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
¶Department of Pharmacy, University Health Network, Toronto, Ontario, Canada;
In this issue
Clinical Journal of the American Society of Nephrology
Vol. 12, Issue 12
December 07, 2017
Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes
Rachel Whitty, Joanne M. Bargman, Alex Kiss, Linda Dresser, Philip Lui
CJASN Dec 2017, 12 (12) 2016-2022; DOI: 10.2215/CJN.00630117
Jump to section
More in this TOC Section
Original Articles
Maintenance Dialysis
Cited By...
- Peritoneal dialysis-associated peritonitis caused by Enterococcus avium
- Variability in Culture-Negative Peritonitis Rates in Pediatric Peritoneal Dialysis Programs in the United States
- Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients
- Peritoneal Dialysis-Associated Peritonitis
- Chryseobacterium indologenes peritonitis in a peritoneal dialysis patient
- Effective Treatment of PD Peritonitis